TREMONT STRATEGIES GROUP LLC for AMAG PHARMACEUTICAL
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical issues; access to women's health pharmaceutical products.
Foreign entity interest: COVIS Pharma GmbH, identified on Line 27, holds the intellectual property underlying AMAG Pharmaceuticals' work and would benefit from AMAG's success in ensuring public access to its product.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LIESL GREBENSTEIN SHEEHAN | — |
Pharmacy PHA
Pharmaceutical issues; access to women's health pharmaceutical products.
Foreign entity interest: COVIS Pharma GmbH, identified on Line 27, holds the intellectual property underlying AMAG Pharmaceuticals' work and would benefit from AMAG's success in ensuring public access to its product.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LIESL GREBENSTEIN SHEEHAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.